Auctus Advisors LLC Makes New Investment in Colgate-Palmolive Company $CL

Auctus Advisors LLC bought a new stake in Colgate-Palmolive Company (NYSE:CL) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,000 shares of the company’s stock, valued at approximately $790,000. Colgate-Palmolive comprises approximately 0.7% of Auctus Advisors LLC’s investment portfolio, making the stock its 7th biggest position.

A number of other hedge funds have also recently made changes to their positions in the company. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP raised its position in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. raised its position in Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after purchasing an additional 245 shares during the last quarter. Global Retirement Partners LLC acquired a new position in Colgate-Palmolive during the 2nd quarter worth about $655,000. Finally, Quadrant Capital Group LLC grew its position in shares of Colgate-Palmolive by 3.7% in the 2nd quarter. Quadrant Capital Group LLC now owns 13,675 shares of the company’s stock valued at $1,243,000 after buying an additional 486 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of CL opened at $84.25 on Friday. The firm has a market cap of $67.59 billion, a PE ratio of 32.16, a price-to-earnings-growth ratio of 3.78 and a beta of 0.28. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The business’s 50 day moving average price is $91.11 and its two-hundred day moving average price is $83.37. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 EPS. On average, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is 80.92%.

Insider Activity at Colgate-Palmolive

In other news, insider John Hazlin sold 20,989 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the sale, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.34% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CL. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Piper Sandler increased their target price on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a report on Tuesday, December 9th. Barclays boosted their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $94.75.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.